Cork, M. J. (2024) “Clinically Meaningful Responses to Dupilumab Among Children Aged 6 Months to 5 Years with Moderate-to-severe Atopic Dermatitis who did Not Achieve Clear or Almost Clear Skin According to the Investigator’s Global Assessment: A Post Hoc Analysis of a Phase 3 Trial”, Acta Dermato-Venereologica, 104, p. adv13467. doi: 10.2340/actadv.v104.13467.